Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Rev. argent. microbiol ; 48(4): 320-324, dic. 2016. ilus, tab
Article in Spanish | LILACS | ID: biblio-1041768

ABSTRACT

En este trabajo se evalúa una prueba rápida in house para la detección de enterobacterias sensibles a cefotaxima, basada en el cambio de pH del rojo fenol debido a la hidrólisis de este antibiótico. Las cepas de enterobacterias procedentes de 1.947 urocultivos se evaluaron mediante los paneles MicroScan y esta prueba in house. Mediante los paneles de MicroScan se estudiaron 499 aislados de enterobacterias, entre los cuales había 27 aislados de Escherichia coli productora de β-lactamasa de espectro extendido (BLEE), 16 de Klebsiella pneumoniae BLEE y una de Klebsiella oxytoca BLEE. La prueba in house mostró una sensibilidad del 98% y una especificidad del 97%, con un valor predictivo negativo del 100% y un valor predictivo positivo del 78%. La prueba in house basada en el cambio de pH es útil en nuestro medio para detectar presuntivamente de forma rápida cepas de enterobacterias con cierta resistencia a cefotaxima.


In this work an "in house" rapid test based on the change in pH that is due to hydrolysis for detecting Enterobacteriaceae susceptible to cefotaxime is evaluated. The strains of Enterobacteriaceae from 1947 urine cultures were assessed using MicroScan panels and the "in house" test. This rapid test includes red phenol solution and cefotaxime. Using MicroScan panels, 499 Enterobacteriaceae isolates were evaluated, which included 27 isolates of Escherichia coli producing extended-spectrum beta-lactamases (ESBL), 16 isolates of Klebsiella pneumoniae ESBL and 1 isolate of Klebsiella oxytoca ESBL. The "in house" test offers the following values: sensitivity 98% and specificity 97%, with negative predictive value 100% and positive predictive value 78%. The "in house" test based on the change of pH is useful in our area for detecting presumptively cefotaxime-resistant Enterobacteriaceae strains.


Subject(s)
Humans , Male , Female , Microbial Sensitivity Tests/methods , Cefotaxime/therapeutic use , Enterobacteriaceae/drug effects , Phenolsulfonphthalein/analysis , beta-Lactamases/analysis , Cefotaxime/pharmacology , Enterobacteriaceae/isolation & purification
2.
Rev. bras. parasitol. vet ; 23(4): 495-500, Oct-Dec/2014. tab, graf
Article in English | LILACS | ID: lil-731261

ABSTRACT

Molecular and morphological methods were evaluated to distinguish between Haemonchus contortus and Haemonchus placei species. A total of 141 H. contortus and 89 H. placei male adult specimens collected from artificially infected lambs were identified individually by PCR analysis, using a species-specific primer pair. These PCR results were used as gold standard for Haemonchus spp. identification. Haemonchus placei presented higher mean spicule and barb lengths than H. contortus (P<0.05). However, some measurements overlapped. For this reason, a discriminate function did not allow the correct identification of 13 H. contortus and one H. placei specimen. The sheath tail length of the third stage larvae (L3), which comprises the distance between the tip of the larval tail and the end of the sheath tail, were measured. Only three of the 485 H. placei larvae (0.619%) had a sheath tail shorter than 85 µm, while only four of the 500 H. contortus larvae (0.8%) presented a sheath tail longer than 85 µm. The results indicated that 6.09% of the male adult specimens would be misclassified based on the discriminate function, while only 0.71% of infective larvae would be misclassified. Therefore, identification of L3 can be used as the first method to indicate the presence of H. placei and/or H. contortus in a population of domestic ruminants.


Métodos moleculares e morfológicos foram avaliados para a identificação de Haemonchus contortus e Haemonchus placei. No total, 141 H. contortus e 89 H. placei machos adultos, obtidos de cordeiros artificialmente infectados, foram identificados individualmente por PCR com o emprego de um par de “primers” espécie-específico. Esses resultados da análise por PCR foram considerados como padrão para a identificação das espécies de Haemonchus. Haemonchus placei apresentou valores médios de espículos e ganchos superiores aos de H. contortus (P<0,05). Entretanto, houve sobreposição de alguns valores. Por essa razão, a função discriminante não permitiu a identificação correta de 13 exemplares de H. contortus e de um, de H. placei. Foi medida a cauda da bainha de larvas infectantes (L3), que compreende a distância entre a ponta da cauda da larva e a ponta da cauda da bainha. Apenas três das 485 L3 de H. placei (0,619%) apresentaram a cauda da bainha com medida inferior a 85 µm e somente em quatro das 500 L3 de H. contortus (0,8%) essa medida foi superior a 85 µm. Os resultados demonstraram que 6,09% dos machos adultos seriam identificados erroneamente com base na função discriminante, enquanto a identificação incorreta de L3 seria de apenas 0,71%. Portanto, a identificação de L3 pode ser utilizada como método inicial para indicar a presença de H. placei e/ou H. contortus em uma população de ruminantes domésticos.


Subject(s)
Adolescent , Adult , Child , Humans , Middle Aged , Aminoacyltransferases , Bacterial Proteins , Hexosyltransferases , Peptidyl Transferases , Penicillin Resistance/genetics , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/genetics , Alleles , Carrier Proteins/genetics , Cefotaxime/pharmacology , Cephalosporins/pharmacology , Communicable Diseases, Emerging/epidemiology , DNA, Bacterial/analysis , Electrophoresis, Gel, Pulsed-Field , Microbial Sensitivity Tests , Muramoylpentapeptide Carboxypeptidase/genetics , Penicillin-Binding Proteins , Pneumococcal Infections/epidemiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects , United States/epidemiology
3.
Rev. argent. microbiol ; 46(1): 14-23, mar. 2014. ilus, tab
Article in Spanish | LILACS | ID: lil-708695

ABSTRACT

Se presentan en este trabajo los resultados de 16 años de vigilancia epidemiológica de meningitis neumocócica llevada a cabo en el Hospital Provincial de Pediatría de Misiones (Argentina), antes de la introducción de la vacuna conjugada al calendario nacional. En el período que va de enero de 1994 a diciembre de 2009 se diagnosticaron 167 casos de meningitis por Streptococcus pneumoniae en niños (1 mes-15 años). La tasa de ataque cada 100 000 niños varió entre 19,2 (1997) y 4,3 (2009), con una media de 10,6 y una tendencia en disminución (y = ""0,689x + 16,52). Esto fue a expensas del grupo de niños entre 1 y 11 meses (94/167, 56 %), en el que disminuyó de 146,6 a 34,8 casos cada 100 000 niños. El 30,7 % de los aislamientos (46/150) fueron resistentes a penicilina y el 16,7 % (25/150) no sensibles a cefotaxima. La resistencia a β-lactámicos se incrementó a partir de 1997 y comenzó a disminuir en 2005. Se detectaron 19 serotipos, predominó el 14 (32 %; 40/125). El 84,8 % de los aislamientos quedaron circunscriptos a nueve serotipos: 14, 5, 1, 7F, 18C, 6B, 9N, 9V y 4. La cobertura teórica en los niños < 2 años y > 2 años fue de 84,1 % (74/88) y 83,8 % (31/37) con la vacuna 10-valente, y de 89,8 % (79/88) y 83,8 % (31/37) con la vacuna 13-valente, respectivamente. La resistencia a penicilina estuvo circunscripta a 8 serotipos (14, 6B, 6A, 9V, 4, 23B, 1 y 19A), y la no sensibilidad a cefotaxima a 3 serotipos (14, 9V y 1), el más importante fue en ambos casos el serotipo 14. Este estudio permitirá evaluar el impacto de la implementación de las vacunas conjugadas en nuestra zona.


We report the results of pneumococcal meningitis surveillance conducted at the Provincial Pediatric Hospital of Posadas, Misiones (Argentina), before the conjugate vaccine was introduced into the national vaccination schedule. Between January 1994 and December 2009, 167 cases of Streptococcus pneumoniae meningitis were diagnosed in children aged 1 month to 15 years. The attack rate/100,000 children ranged from 19.2 (1997) to 4.3 (2009), with a mean of 10.6 and a tendency to decrease (y=""0.689x+16.52). The number of cases per 100,000 children decreased from 146.6 to 34.8 and particularly involved the group of children aged 1 to 11 months (94/167, 56%). Thirty point seven percent (30.7%) (46/150) of the isolates were resistant to penicillin whereas 16.7% (25/150) were non-susceptible to cefotaxime. β-lactam resistance increased as from 1997 and began to decline in 2005. Nineteen serotypes were detected; type 14 was predominant and accounted for 32% (40/125). Eighty four point eight percent (84.8%) of the isolates were circumscribed to nine serotypes: 14, 5, 1, 7F, 18C, 6B, 9N, 9V and 4. Theoretical coverage for patients aged <2 years and >2 years was 84.1% (74/88) and 83.8% (31/37) for the 10-valent vaccine and 89.8 % (79/88) and 83.8% (31/37) for the 13-valent vaccine respectively. Penicillin resistance was restricted to 8 serotypes (14, 6B, 6A, 9V, 4, 23B, 19A1) and nonsusceptibility to cefotaxime was circumscribed to 3 serotypes (14, 9V and 1). This study will allow to evaluate the impact of the implementation of conjugate vaccines on our area.


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Meningitis, Pneumococcal/epidemiology , Argentina/epidemiology , Cefotaxime/pharmacology , Drug Resistance, Multiple, Bacterial , Meningitis, Pneumococcal/microbiology , Meningitis, Pneumococcal/prevention & control , Penicillin Resistance , Pneumococcal Vaccines , Population Surveillance , Prevalence , Retrospective Studies , Serotyping , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/isolation & purification , Vaccination , Vaccines, Conjugate
4.
Annals of Laboratory Medicine ; : 210-215, 2014.
Article in English | WPRIM | ID: wpr-163732

ABSTRACT

BACKGROUND: Streptococcus pneumoniae causes life-threatening infections such as meningitis, pneumonia, and febrile bacteremia, particularly in young children. The increasing number of drug-resistant isolates has highlighted the necessity for intervening and controlling disease. To achieve this, information is needed on serotype distribution and patterns of antibiotic resistance in children. METHODS: All cases of invasive pneumococcal disease (IPD) in children aged less than 15 yr recorded at King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, were reviewed for serotyping and antibiotic susceptibility. Isolates were collected from 78 consecutive patients with IPD between 2009 and 2012. All collected isolates were subjected to serotyping by co-agglutination, sequential multiplex PCR, and single PCR sequetyping as previously described. RESULTS: The most frequently isolated IPD serotypes were 23F, 6B, 19F, 18C, 4, 14, and 19A, which are listed in decreasing order and cover 77% of total isolates. The serotype coverage for the pneumococcal conjugate vaccine (PCV)7, PCV10, and PCV13 was 77%, 81%, and 90%, respectively. Results from sequential multiplex PCR agreed with co-agglutination results. All serotypes could not be correctly identified using single PCR sequetyping. Minimum inhibitory concentration showed that 50 (64%) isolates were susceptible to penicillin, whereas 70 (90%) isolates were susceptible to cefotaxime. CONCLUSIONS: The most common pneumococcal serotypes occur with frequencies similar to those found in countries where the PCV has been introduced. The most common serotypes in this study are included in the PCVs. Addition of 23A and 15 to the vaccine would improve the PCV performance in IPD prevention.


Subject(s)
Adolescent , Child , Child, Preschool , Humans , Infant , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Cefotaxime/pharmacology , DNA, Bacterial/analysis , Meningitis/diagnosis , Microbial Sensitivity Tests , Multiplex Polymerase Chain Reaction , Penicillins/pharmacology , Pneumococcal Vaccines/immunology , Pneumonia/diagnosis , Protein Tyrosine Phosphatases/genetics , Retrospective Studies , Saudi Arabia , Serotyping , Streptococcus pneumoniae/drug effects
5.
Annals of Laboratory Medicine ; : 141-144, 2013.
Article in English | WPRIM | ID: wpr-216008

ABSTRACT

We report a case of CTX-M-55-type extended-spectrum beta-lactamase (ESBL)-producing Shigella sonnei infection in a 27-year-old Korean woman who had traveled to China. The patient was admitted to the hospital due to abdominal pain, watery diarrhea, and fever (39.3degrees C). S. sonnei was isolated from her stool specimens, and the pathogen was found to be resistant to cefotaxime due to CTX-M-55-type ESBL. Insertion sequence (IS)Ecp1 was found upstream of the blaCTX-M-55 gene. The blaCTX-M-55 gene was transferred from the S. sonnei isolate to an Escherichia coli J53 recipient by conjugation. Pulsed-field gel electrophoresis and Southern blotting revealed that the blaCTX-M-55 gene was located on a plasmid of approximately 130 kb.


Subject(s)
Adult , Female , Humans , Anti-Bacterial Agents/pharmacology , Asian People , Cefotaxime/pharmacology , China , Drug Resistance, Bacterial/drug effects , Dysentery, Bacillary/diagnosis , Electrophoresis, Gel, Pulsed-Field , Escherichia coli/metabolism , Feces/microbiology , Plasmids/chemistry , Republic of Korea , Shigella sonnei/enzymology , Travel , beta-Lactamases/genetics
6.
Rev. Col. Méd. Cir. Guatem ; 6(3[2?]): 51-56, jul.-dic. 2011. graf
Article in Spanish | LILACS | ID: biblio-835524

ABSTRACT

Objetivos: Determinar la frecuencia de microorganismos más comunes durante el período 2005-2010 en pacientes intrahospitalarios y ambulatorios y en las unidades de cuidados críticos con sospecha de infección urinaria, así como también establecer el padrón de resistencia acorde a los datos presentados...


Subject(s)
Humans , Cefotaxime/pharmacology , Urinary Tract Infections/urine , Urinary Tract Infections/therapy , Clinical Laboratory Techniques/methods
7.
Pakistan Journal of Pharmacology. 2010; 27 (1): 43-47
in English | IMEMR | ID: emr-178272

ABSTRACT

During the present study an effort has been made to determine the sensitivity of clinical isolates to complish this task, ninety clinical isolates of Escherichia coli [n-41], Klebsialla spp. [n-12], Proteus spp [n-6], Pseudomonas aeruginosa [n-11], and Staphylococcus aureus [n-20] were collected from different pathological laboratories and medical center in Karachi. An in vitro study of these clinical isolates were carried out by ICLS reference Disk diffusion [Kirby-Bauer] method, using Cephradine and Cefotaxime. An attempt has been made to measured the Zone if inhibition produced by Cephradine and Cefotaxime against these clinical isolates. Results indicated that both Cephradine and Cefotaxime has excellent in-vitro antibacterial activity, but Cefotaxime had relatively broad spectrum of activity against most of clinical isolates tested its mean that Cefotaxime is more effective against Gram-positive and Gram-negative bacteria. On the basis of present study it can be evaluated that Cephradine and Cefotaxime were two very good antibacterial agent in the field of antimicrobial Chemotherapy but different clinical isolates had started to develop resistance to these antibiotics, which is shocking for prescriber because these two cephalosporins are massively prescribe for most of infections in our country


Subject(s)
Cefotaxime/pharmacology , Drug Resistance, Microbial , Microbial Sensitivity Tests , Drug Resistance, Bacterial , Gram-Positive Bacteria/drug effects , Gram-Negative Bacteria/drug effects
8.
Yonsei Medical Journal ; : 768-774, 2010.
Article in English | WPRIM | ID: wpr-53346

ABSTRACT

PURPOSE: Extended spectrum beta-lactamases (ESBLs) are cephalosporinases that confer resistance to a wide variety of oxyimino cephalosporins and create serious therapeutic problems. In addition, the quinolone resistance qnr genes are becoming increasingly prevalent in clinical isolates, some of which also produce ESBL. This study was designed to evaluate the occurrence and genotypic distribution of ESBL producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) as well as the prevalence and distribution of qnr genes in ESBL-producing isolates in a tertiary care hospital in Korea. MATERIALS AND METHODS: We tested a total of 111 ESBL-producing isolates of E. coli and K. pneumoniae, which were collected at Kyung Hee Medical Center from November 2006 to June 2008. ESBL production was determined by the Clinical and Laboratory Standards Institute (CLSI) ESBL confirmatory test. The cefotaxime and ceftazidime resistance of the ESBL-producers were transferred to azide-resistant E. coli J53 by conjugation. The presence and identity of ESBL and qnr genes were determined by polymerase chain reaction (PCR) and nucleotide sequencing. RESULTS: The prevalence of ESBLs was 17.7% (297/1,680) of E. coli and 26.5% (240/904) of K. pneumoniae in our hospital during the study periods. Of the 111 collected isolates, 69 isolates were E. coli and 42 isolates were K. pneumoniae. The most prevalent ESBL genotype was CTX-M15. Among the ESBL-producing isolates, 4 E. coli (5.8%) and 17 K. pneumoniae (40.5%) contained qnr genes. qnrB4 was the most frequent type in both E. coli and K. pneumoniae. CONCLUSION: CTX-M15 was the most frequently encountered ESBL. In addition, a high prevalence of qnr genes among ESBL-producing K. pneumoniae was identified in this study.


Subject(s)
Humans , Azides/pharmacology , Bacterial Proteins/metabolism , Cefotaxime/pharmacology , Ceftazidime/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Escherichia coli/drug effects , Escherichia coli Infections/microbiology , Escherichia coli Proteins/metabolism , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Korea , Microbial Sensitivity Tests , Polymerase Chain Reaction , beta-Lactamases/metabolism
9.
Indian J Med Microbiol ; 2007 Jul; 25(3): 230-5
Article in English | IMSEAR | ID: sea-53713

ABSTRACT

PURPOSE: To describe the changes in antibiotic susceptibility patterns of common intensive care unit pathogens with time from the medical intensive care unit of a tertiary care hospital. METHODS: A prospective observational study was conducted in the medical intensive care unit (MICU) of a 2100 bed tertiary care hospital in South India. All data regarding patient characteristics, disease characteristics, infective agents, identified along with their antibiotic sensitivity patterns and patient outcomes were prospectively recorded in MICU data base. Various bacterial pathogen antibiotic sensitivity patterns from August 2004 to May 2005 were prospectively documented. During this period 491 patients were admitted to the MICU. Data were analyzed using excel spreadsheets. RESULTS: Ceftazidime resistance reduced in Klebsiella spp. while cefotaxime resistance increased. In E. coli however, ceftazidime and cefotaxime resistance increased. Klebsiella resistance to cefotaxime and ceftazidime ranged from 25-50% and 14-91%, while E. coli resistance to these antibiotics ranged from 50-70% and 50 to 80% respectively. In Pseudomonas and the non-fermenting gram-negative bacteria (NFGNB) ceftazidime resistance decreased. Third generation cephalosporin resistance seemed to be reducing in the NFGNB, however, carbapenem resistance appeared to be increasing, possibly due to their increasing use. CONCLUSIONS: This study demonstrates the trend in antibiotic susceptibility pattern (AST) of common gram negative infections seen in intensive care units. It demonstrates the changes seen especially after a change in the protocol antibiotic. Changes in the AST patterns of Klebsiella, E. coli, Pseudomonas and non-fermenting gram negative bacteria were seen. The data on the changing antibiotic susceptibility trends we believe is an important pillar in our efforts at infection control especially in intensive care settings.


Subject(s)
Carbapenems/pharmacology , Cefotaxime/pharmacology , Ceftazidime/pharmacology , Cephalosporins/pharmacology , Drug Resistance, Bacterial , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/microbiology , Humans , India , Intensive Care Units , Microbial Sensitivity Tests
10.
Indian J Pathol Microbiol ; 2007 Jul; 50(3): 669-70
Article in English | IMSEAR | ID: sea-73428

ABSTRACT

Klebsiella pneumoniae has long been a prominent cause of nosocomial infections and outbreaks have been observed in the intensive care units and in high risk groups. We present here a brief report on an outbreak of Klebsiella pneumoniae which occurred in a neonatal intensive care unit in our teaching hospital. As neonates are at highest risk for acquisition of Klebsiella pneumoniae producing extended spectrum beta-lactamase, infection control policies and procedures should be strictly followed to prevent such outbreaks.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefotaxime/pharmacology , Ceftazidime/pharmacology , Ceftriaxone/pharmacology , Cephalosporin Resistance , Cross Infection/epidemiology , Disease Outbreaks , Hospitals, Teaching , Humans , India/epidemiology , Infant, Low Birth Weight , Infant, Newborn , Intensive Care Units, Neonatal , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/classification , beta-Lactamases/biosynthesis
11.
Col. med. estado Táchira ; 16(2): 19-21, abr.-jun. 2007. tab, graf
Article in Spanish | LILACS | ID: lil-530993

ABSTRACT

En este trabajo se presenta una revisión de 5 años (2001-2006) de pacientes en área pediátrica con el diagnóstico de apendicitis aguda ingresados en el servicio de cirugía pediátrica del Hospital Dr. Patrocinio Peñuela Ruíz del Estado Táchira para determinar las complicaciones que se presentaron en los casos estudiados. Para tal fin se diseño un estudio retrospectivo el cual reporto un total de 143 pacientes que corresponde al total de pacientes ingresados de los cuales 6,2 por ciento presentaron alguna complicación y las mas frecuente fueron las de tipo infeccioso en herida operatoria.


Subject(s)
Humans , Male , Female , Child , Appendicitis/surgery , Appendicitis/complications , Appendicitis/diagnosis , Cefotaxime/administration & dosage , Fever/diagnosis , Medical Records , Metronidazole/administration & dosage , Sepsis/complications , Vancomycin/administration & dosage , Appendectomy/methods , Bacteroides fragilis/isolation & purification , Cefotaxime/pharmacology , Postoperative Complications/etiology , Metronidazole/pharmacology , Pediatrics , Vancomycin/pharmacology
12.
Indian J Med Microbiol ; 2006 Jul; 24(3): 208-11
Article in English | IMSEAR | ID: sea-53807

ABSTRACT

Increasing resistance to third generation cephalosporins has become a cause for concern especially among Enterobacteriaceae that cause nosocomial infections. The prevalence of extended spectrum beta-lactamases (ESBLs) among members of Enterobacteriaceae constitutes a serious threat to current beta-lactam therapy leading to treatment failure and consequent escalation of costs. A detailed study was initiated to identify the occurrence of ESBLs among the Enterobacteriaceae isolates at a tertiary care hospital using the double disk potentiation technique. Antibiogram profiles were determined to commonly used antibiotics and confirmation of ESBLs production was carried out by the disk diffusion assay using ceftazidime and cefotaxime in the presence and absence of clavulanic acid. Our results indicate that the majority of ESBLs were expressed in Escherichia coli.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefotaxime/pharmacology , Enterobacteriaceae/drug effects , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests , beta-Lactam Resistance , beta-Lactamases/metabolism
13.
Article in English | IMSEAR | ID: sea-16743

ABSTRACT

BACKGROUND AND OBJECTIVES: Resistance in Salmonella enterica var Typhi (S. Typhi) to chloramphenicol, amoxicillin and co-trimoxazole has posed a challenge to treatment of typhoid fever. Ciprofloxacin has been the empirical therapy of choice, but the recent increase in minimum inhibitory concentration (MIC) to ciprofloxacin in S. Typhi, not detectable by disc diffusion (DD) tests, may result in delayed response and serious complications. Nalidixic acid (NA) resistance has been used as an indirect evidence of increased ciprofloxacin MIC in S. Typhi. We evaluated the predictive value of NA resistance for fluoroquinolone resistance in clinical isolates of S. Typhi. METHODS: A total of 70 clinical isolates of S. Typhi were tested for antimicrobial susceptibility according to the National Committee for Clinical Laboratory Standards (NCCLS) method. MIC to fluoroquinolones was carried out by the agar dilution method. RESULTS: Thirteen (18.6 %) isolates were resistant to amoxicillin, chloramphenicol and cotrimoxazole; all were sensitive to ciprofloxacin and cefotaxime. Fifty (71.4%) were resistant to NA. Nineteen (27.1 %) isolates were resistant to ciprofloxacin by MIC tests. The MIC for ciprofloxacin was 0.03-4 microg/ml for NA(S) and 0.25-4 microg/ml for NA(R) isolates. NA susceptibility showed a predictive value of 95 per cent for ciprofloxacin susceptibility while NA resistance had a predictive value of 36 per cent for ciprofloxacin resistance. Thirty isolates studied were sensitive to gatifloxacin; MIC values were 0.03-0.5 microg/ml for NA(S) and 0.25-0.5 microg/ml for NA(R) isolates. INTERPRETATION AND CONCLUSION: NA susceptibility was a good marker for fluoroquinolone susceptibility but NA resistance had a poor predictive value for ciprofloxacin resistance. NA resistant isolates should be tested for ciprofloxacin MIC before deciding a change in therapeutic regimen. Higher MIC for gatifloxacin was also noticed in NA resistant isolates.


Subject(s)
Biomarkers , Cefotaxime/pharmacology , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial , Fluoroquinolones/pharmacology , Humans , Microbial Sensitivity Tests , Nalidixic Acid/pharmacology , Salmonella typhi/drug effects
14.
West Indian med. j ; 55(3): 200-204, Jun. 2006.
Article in English | LILACS | ID: lil-472319

ABSTRACT

A 16-year-old adolescent presented with fever, lethargy and vomiting associated with mild dehydration. This was followed less than 24-hours later by loss of consciousness, seizures and clinical brain death. She had no prior medical illness, no hospital or frequent antibiotic exposure. There was no evidence of soft tissue or skin infection. Management included intravenous fluids, ampicillin and cefotaxime parenterally, dexamethasone, endotracheal intubation and mechanical ventilation. Her neurologic examination remained unchanged with areflexia, flaccid paralysis and fixed pupils. Post-mortem examination revealed an eight-centimetre right fronto-parietal lobe brain abscess. Cultures were positive for methicillin resistant Staphylococcus aureus. Although formerly a nosocomial pathogen affecting debilitated patients in the hospital setting, S aureus that is methicillin resistant is emerging as a community acquired pathogen affecting previously well patients.


Una adolescente de 16 años de edad se presentó con fiebre, letargia y vómitos, asociados con deshi-dratación ligera. Estos síntomas fueron seguidos en menos de 24 horas por pérdida de conciencia, ataques y muerte clínica del cerebro. Con anterioridad, la paciente no había tenido enfermedad médica, ni hospitalización, ni tratamiento frecuente con antibióticos. No había evidencia de tejidos blandos o infección de la piel. El tratamiento incluyó líquidos intravenosos, ampicilina y cefotaxima de forma parenteral, dexametasona, entubación endotraqueal, y ventilación mecánica. El examen neurológico permaneció invariable con areflexia, parálisis flácida, y pupilas fijas. El examen post-mortem reveló un absceso cerebral de ocho centímetros en el lóbulo fronto-parietal derecho. Los cultivos resultaron positivos al Staphylococcus aureus resistente a la meticilina. Aunque visto an-teriormente como un patógeno nosocomial que afecta a los pacientes debilitados en el entorno hos-pitalario, el S aureus resistente a la meticilina está surgiendo como un patógeno extrahospitalario (ie adquirido en la comunidad) y afecta a pacientes previamente sanos. 1Equivalente acuñado aquí para el término inglés caseness, a saber, criterios que definen el estatus de caso sobre la base de la presencia de sintomatologia clinicamente significativa.


Subject(s)
Humans , Female , Adolescent , Brain Abscess/microbiology , Community-Acquired Infections/complications , Staphylococcal Infections/complications , Methicillin Resistance , Staphylococcus aureus/isolation & purification , Brain Abscess/diagnosis , Ampicillin/pharmacology , Ampicillin/therapeutic use , Cefotaxime/pharmacology , Cefotaxime/therapeutic use , Fatal Outcome , Community-Acquired Infections/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects
15.
Journal of Korean Medical Science ; : 666-671, 2006.
Article in English | WPRIM | ID: wpr-191664

ABSTRACT

Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection as a complication of end stage liver disease. The outcome is related to the severity of hepatorenal function, gastrointestinal bleeding, and many others; however it is not well known whether the infection acquisition sites have an effect on the prognosis of SBP. In order to identify the prognostic significance of the acquisition sites, we studied 106 patients who were diagnosed as culture positive SBP between October 1998 and August 2003. Thirty-two episodes were nosocomial and 74 were community acquired. Gramnegative bacilli such as Escherichia coli were dominant in both of the nosocomial and community-acquired SBPs. Despite significantly higher resistance to cefotaxime in nosocomial isolates compared to community-acquired isolates (77.8% vs. 13.6%, p=0.001), no difference was found regarding short or long term prognosis. Infection acquisition sites were not related to short or long term prognosis either. Shock, gastrointestinal bleeding and renal dysfunction were related to short term prognosis. Only Child-Pugh class C was identified as an independent prognostic factor of long-term survival.


Subject(s)
Middle Aged , Male , Humans , Female , Aged , Time Factors , Survival Rate , Shock/etiology , Prognosis , Peritonitis/complications , Multivariate Analysis , Klebsiella pneumoniae/drug effects , Kidney Diseases/etiology , Gastrointestinal Hemorrhage/etiology , Escherichia coli/drug effects , Drug Resistance, Bacterial , Cross Infection/complications , Community-Acquired Infections/complications , Ciprofloxacin/pharmacology , Cefotaxime/pharmacology , Bacterial Infections/complications , Anti-Bacterial Agents/pharmacology
16.
Acta Med Indones ; 2005 Oct-Dec; 37(4): 187-9
Article in English | IMSEAR | ID: sea-47185

ABSTRACT

AIM: To determine the prevalence of diabetic foot according to severity of disease, causing microorganism, resistance pattern of microorganism, and blood glucose level of diabetes mellitus (DM) patients at Koja Regional General Hospital, to provide additional information to improve patient follow-up. METHODS: This study is designed as a descriptive cross-sectional study. The population in this study consists of patients with diabetes mellitus patients admitted and treated at the internal medicine outpatient clinic of Koja Regional General Hospital from January 1999 to December 2004. RESULTS: We obtained a prevalence of diabetic foot according to the causal microorganisms as follows: Pseudomonas (40.9%), followed by Staphylococcus (29.5%). The prevalence of diabetic foot according to the blood glucose groups were: 9.5% having random blood glucose concentration of 150-200 mg/dl, 9.3% 201-250 mg/dl, 30% 251-300 mg/dl, and 30% >300 mg/dl. According to Wagner classification, most cases were classified as 0 degree, highly effective antibiotics treatment followed by fifth degree at 13.5%. In addition, the Pseudomonas were Cefotaxim 53.8% and Ceftriaxon 41.5%. CONCLUSION: According to the results of this study, the most common cause of diabetic foot is Pseudomonas, and the effective antibiotics treatment is Ceftriaxone and Cefotaxim. The prevalence of diabetic foot has increased along with increased blood glucose level, and according to Wagner classification, 0 degree was the most common, but fifth degree was also higher than 2nd to 4th degree.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Infections/complications , Blood Glucose/analysis , Cefotaxime/pharmacology , Cross-Sectional Studies , Diabetic Foot/blood , Hospitals, General , Humans , Indonesia/epidemiology , Prevalence , Pseudomonas/drug effects , Staphylococcus/isolation & purification , Streptococcus/isolation & purification
17.
Rev. méd. Chile ; 132(5): 549-555, mayo 2004. tab
Article in Spanish | LILACS | ID: lil-384412

ABSTRACT

Background : Streptococcus agalactiae or group B streptococcus, GBS, is the leading cause of neonatal and maternal infections and an opportunistic pathogen in adults with underlying disease. In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed. Aim: To determine the serotype distribution and antimicrobial susceptibility of isolates of S agalactiae collected from infections and colonization and to assess the genetic mechanisms of macrolide and clindamycin resistance. Material and methods: A total of 100 GBS isolates were collected between 1998 and 2002, in Santiago, Chile. They were isolated from the amniotic fluid from patients with premature rupture of membranes (7 isolates), blood from neonatal sepsis (10 isolates), neonate colonizations (2 strains), skin and soft tissue infections (7 isolates), urinary tract infections (5 isolates), genital infections (3 isolates), articular fluid (one isolate), and 65 strains were recovered from vaginal colonization55. Results: Serotypes Ia, II and III were the predominant serotypes identified in our study, accounting for 90 (90 percent) of the strains. Five isolates belonged to serotypes Ib (5 percent) and two (2 percent) to serotype V respectively; no strains belonging to serotype IV were found. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four isolates (4 percent) were resistant to both erythromycin (MIC >64 µg/ml) and clindamycin (MIC >64 µg/ml). The strains had a constitutive macrolide-lincosamide-streptogramin (cMLSB) resistance phenotype and the erm(A) gene was present in the four isolates. Conclusions: Serotypes Ia, II and III were the predominant serotypes in this study. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four (4 percent) strains were resistant to both erythromycin and clindamycin. The cMLSB resistance phenotype, and the erm(A) gene was detected in resistant strains (Rev MÚd Chile 2004; 132: 549-55).


Subject(s)
Streptococcus agalactiae/isolation & purification , Streptococcus agalactiae , Ampicillin/pharmacology , Cefotaxime/pharmacology , Clindamycin/pharmacology , Erythromycin/pharmacokinetics , Penicillins/pharmacology , Drug Resistance, Microbial , Serotyping , Microbial Sensitivity Tests/methods , Tetracycline/pharmacology
18.
Article in English | IMSEAR | ID: sea-51723

ABSTRACT

The present study was conducted to isolate aerobic as well as anaerobic microbes from patients of gingivitis and adult periodontitis and to study the susceptibility patterns of these isolates to different antibiotics. In our study all the samples belonging to the control as well as the study groups yielded microbes. Aerobes and facultative anaerobes were isolated from 100 percent and 96 percent cases of normal gingiva and orodental infections respectively. Anaerobes were isolated from 80 percent of the normal gingival samples and 97 percent of the cases of orodental infections. Metronidazole was found to be the best for the anaerobes while the aerobes and facultative anaerobes showed good susceptibility to cefazolin and cefotaxime.


Subject(s)
Aggregatibacter actinomycetemcomitans/drug effects , Adult , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Bacteria, Aerobic/drug effects , Bacteria, Anaerobic/drug effects , Cefazolin/pharmacology , Cefotaxime/pharmacology , Drug Resistance, Bacterial , Gingiva/microbiology , Gingivitis/microbiology , Humans , Metronidazole/pharmacology , Microbial Sensitivity Tests , Peptostreptococcus/drug effects , Periodontitis/microbiology , Staphylococcus/drug effects , Veillonella/drug effects
19.
Journal of Korean Medical Science ; : 319-324, 2003.
Article in English | WPRIM | ID: wpr-29062

ABSTRACT

There have been conflicting data about the interactions between vancomycin and beta-lactam agents against Staphylococcus aureus strains with heterogeneous resistance to vancomycin. We evaluated the efficacy of these combinations against Mu 3 and heterogeneously vancomycin-resistant S. aureus (hetero-VRSA) strains which were isolated from Korean patients using a population analysis method. Antagonistic effects were observed when less than 1 g/mL of beta-lactam antibiotics was combined with vancomycin, whereas synergistic effects were noticed with more than 4 microgram/mL of beta-lactam antibiotics. The antagonistic effects at low concentrations of beta-lactams were most prominent at 2 microgram/mL of vancomycin, which were the vancomycin MICs of tested hetero-VRSA strains. This study showed the variable effects of vancomycin- beta-lactam combinations depending on the concentrations of beta-lactam antibiotics and this property could be used to develop screening methods for hetero-VRSA strains.


Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Cefotaxime/pharmacology , Drug Synergism , In Vitro Techniques , Microbial Sensitivity Tests , Oxacillin/pharmacology , Staphylococcus aureus/drug effects , Vancomycin/pharmacology , Vancomycin Resistance , beta-Lactam Resistance
20.
Rev. chil. infectol ; 18(1): 7-19, 2001. tab, graf
Article in Spanish | LILACS | ID: lil-286985

ABSTRACT

Las cefalosporinas son uno de los grupos de mayor importancia dentro de los ß-lactámicos. Existen diversas clasificaciones de esta moléculas, siendo la más utilizada aquella que agrupa a estos compuesto de acuerdo a propiedades estructurales, microbiológicas y desarrollo histórico: primera a cuarta generación. Las cefalosporinas de tercera generación han sido ampliamente utilizadas, pero la emergencia de resistencia bacteriana fundamentalmente derivada de la producción de ß-lactamasas tanto cromosomales como plasmidiales, ha limitado el uso de estos compuestos. Las cefalosporinas de cuarta generación se caracterizan por la presencia de un nitrógeno cuaternario en C, además de mantener el grupo metoxi-imino aminotiazolil en C. Presentan una elevada penetración intracelular a través de la membrana externa de bacilos Gram negativos y tienen una baja afinidad por enzimas que degradan cefalosporinas de tercera generación. Cefepime, una cefalosporina de cuarta generación, demostró una mayor actividad inhibitoria sobre cepas chilenas de Klebsiella pneumoniae y Escherichia coli productoras de ß- lactamasa de espectro extendido, que cefotaxima y ceftazidima


Subject(s)
Humans , Cephalosporins/pharmacology , Communicable Diseases/drug therapy , Cefotaxime/pharmacology , Ceftazidime/pharmacology , Cephalosporin Resistance , Cephalosporins/chemistry , Cephalosporins/classification , Drug Resistance, Microbial , Lactams/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL